Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02008045 · ClinicalTrials.gov registry record
MR Imaging of Perinatal Brain Injury
A clinical trial of Perinatal White Matter Brain Injury, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 557
- Enrollment target
- 1
- Study location
NCT02008045: Completed study of Perinatal White Matter Brain Injury, sponsored by University of Pittsburgh.
NCT02008045 is a study of Perinatal White Matter Brain Injury that has completed, run by University of Pittsburgh. The registered enrollment target is 557 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02008045, a study of Perinatal White Matter Brain Injury, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 557 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to collect and compare information from cranial ultrasounds, magnetic resonance imaging scans, neurological exam and neuropsychological assessments of children. The investigators hope that the information collected in this study will help with early screening, diagnosis and treatment of brain injury in newborns as well as identify a connection between MR imaging (MRI-magnetic resonance imaging, MRS-magnetic resonance spectroscopy) and neurodevelopmental outcome.
Primary Outcome
Administration of neurodevelopmental testing and completion of parent questionnaires regarding the child's development.
Conditions Studied
Interventions
- DEVICE Magnetic Resonance Imaging
- BEHAVIORAL Neurodevelopmental Testing
Study Locations (1)
Pennsylvania
- Children's Hospital of Pittsburgh of UPMC - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 557 participants |
| Start Date | 2009-07-01 |
| Est. Completion | 2025-06-02 |
What the finished NCT02008045 record still lists
NCT02008045 is an observational study that tracks outcomes without assigning an intervention. The registered 557 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Perinatal White Matter Brain Injury appearing as the primary indexed condition, and to 2 interventions - of which Magnetic Resonance Imaging is the first listed.
NCT02008045 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02008045 about?
NCT02008045 is a clinical study titled "MR Imaging of Perinatal Brain Injury". The purpose of this study is to collect and compare information from cranial ultrasounds, magnetic resonance imaging scans, neurological exam and neuropsychological assessments of children. The investigators hope that the information collected in this study will help with early screening, diagnosis ...
What is the current status of trial NCT02008045?
This trial is currently completed. The enrollment target is 557 participants. The study started on 2009-07-01. Estimated completion is 2025-06-02.
What conditions does trial NCT02008045 study?
This clinical trial studies the following conditions: Perinatal White Matter Brain Injury.
What interventions are being tested in trial NCT02008045?
The interventions under investigation include: Magnetic Resonance Imaging (DEVICE), Neurodevelopmental Testing (BEHAVIORAL).
Who is sponsoring clinical trial NCT02008045?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02008045 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05708885 · 557 participants · NA
Striated Esophageal Motor Function Modulation in Health and Disease
- NCT07173751 · 558 participants · Phase 3
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
- NCT06074588 · 556 participants · Phase 3
Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004)
- NCT06693622 · 556 participants
Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI